Gliadel: payments to doctors
Payments that named Gliadel as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $41K
- Providers
- 794
- Transactions
- 1,936
- Average per transaction
- $21
The per-transaction average — $21 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 794 providers the average total is $51, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Arbor Pharmaceuticals, Inc. | $34,634 | 85.3% |
| Azurity Pharmaceuticals, Inc. | $5,961 | 14.7% |